Features

What does the bankruptcy of CARD, the largest autism treatment company in the U.S., have to teach us about the role of private equity in health care?

The leading U.S. therapy for autism is no panacea and has shown mixed results. Critics say it’s time to look for alternatives—and consult people with autism.

Proto.life interviews law professor and ethicist Nita Farahany and techno-humanist Aza Raskin at the BrainMind Summit.

The link between dementia and neuroplasticity inspires researchers to test psychedelics as a potential treatment for cognitive impairment.

Why do so many people in industrialized Western societies have unhealthy microbiomes that lack diversity?

How should medical AI be regulated, and who is responsible when deadly mistakes occur?

Combining AI with traditional wet lab work creates a virtuous circle from lab to data and back to the lab.

The emerging field of disaster microbiology builds on the fact that human health is inherently interconnected with animals, plants, microbes, and the environment—for better or worse.

But consumers are haunted by the ghosts of zero-calorie sweeteners past.

As head of the government’s new federal agency, she’s attacking a wide range of problems from the molecular to the societal.

It feels like we’ve been here before. Here’s why it’s different this time.

VR workout apps like Supernatural are inviting an older, more gender-balanced audience to join the virtual world.

As more people seek help for their mental health, simple techniques that link mind and body are powerful alternatives to traditional talk therapy.

Tech companies building products that focus on women’s health still struggle to attract VC funding.

Scientists have created an organism that defies the rules of biology by using nonstandard amino acids. And you probably have some questions.